Brad Pohlman, MD, Oncology, Cleveland, OH, Cleveland Clinic

BradLPohlmanMD

Oncology Cleveland, OH

Hematologic Oncology

Staff, Department of Hematology and Medical Oncology, Vice Chair for Operations, Taussig Cancer Institute, Cleveland Clinic

Dr. Pohlman is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Pohlman's full profile

Already have an account?

Education & Training

  • University of Minnesota at Fairview
    University of Minnesota at FairviewFellowship, Hematology/Oncology, 1989 - 1993
  • University of Wisconsin
    University of WisconsinResidency, Internal Medicine, 1985 - 1989
  • Indiana University School of Medicine
    Indiana University School of MedicineClass of 1985

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2003 - Present
  • PA State Medical License
    PA State Medical License 2003 - 2006
  • IL State Medical License
    IL State Medical License 2003 - 2023
  • MI State Medical License
    MI State Medical License 2002 - 2019
  • OH State Medical License
    OH State Medical License 1993 - 2022
  • MN State Medical License
    MN State Medical License 1989 - 1994
  • WI State Medical License
    WI State Medical License 1986 - 1995
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2010-2014
  • America's Top Doctors for Cancer Castle Connolly, 2009-2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Outcomes and Factors Impacting Use of Axicabtagene Ciloleucel in Refractory and Relapsed Large B-Cell Lymphoma: An Intent-to-Treat Analysis
    Brad Pohlman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Targeted Treatment and Survival Following Relapse after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia and MDS in the Contemporary Era
    Brad Pohlman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Interactions between Donor Activating Killer Immunoglobulin-like Receptors (KIRs) and Somatic Mutations and Their Association with Outcomes after Allogeneic Hematopoie...
    Brad Pohlman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Association of MHC Class I Chain-Related Gene a (MICA) Polymorphisms with Allogeneic Hematopoietic Cell Transplantation Outcomes in Acute Myeloid Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Phase I Trial of Carfilzomib + R-CHOP (CarR-CHOP) for Frontline Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL) 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Cleveland Clinic Cancer Doctor
    Cleveland Clinic Cancer DoctorNovember 13th, 2016

Professional Memberships

Hospital Affiliations